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ABSTRACT
The analysis of weakly basic drugs such as verapamil by reverse-phase liquid chromatography remains a problem, particularly when
present in combination with other drugs such as amphoteric compounds like trandolapril. In this study, the simple, accurate, precise and
fully validated RP-LC method for the simultaneous determination of verapamil and trandolapril in combined dosage forms has been
developed. The LC method allowed quantitation over the ranges of 0.50-18.00 µg/mL and 0.05-1.00 µg/mL for verapamil and trandolapril,
respectively. The detection limits were found to be 0.008 μg/mL and 0.018 μg/mL for verapamil and trandolapril, respectively. Moreover,
pKa values of verapamil and trandolapril were determined via the dependence of the retention factor on the pH of the mobile phase for
ionizable substances. The effect of the mobile phase composition on the ionization constant was studied by measuring the pKa at different
methanol-water mixtures, ranging 50-65% (v/v). It was shown that RP-HPLC was suitable for the high throughput analysis of the combination of verapamil and trandolapril. The method also allows a number of cost and time saving benefits and can be readily employed for
the analysis of pharmaceutical formulations. The method has been verified, without any interference from excipients, for the concurrent
analysis of these compounds in tablets.
Key words: verapamil, trandolapril, ramipril, pKa, HPLC, simultaneous determination

INTRODUCTION
The inhibitors of the angiotensin-converting enzyme
(ACE inhibitors) are widely used for the treatment of mild
to moderate hypertension and heart failure, either alone or in
conjunction with other drugs(1). Trandolapril (TRA, (2S, 3aR,
7aS)-1-[(S)-N-[(S)-1-(ethoxycarbonyl)-3-phenyl propyl]
alanyl] hexahydro-2-indolinecarboxylic acid), is a long
acting, highly lipophilic non-peptide, ACE inhibitor with a
carboxyl group but without sulphydry1 group(2) (Figure 1A).
It is used for the management of hypertension and for the
stable patients who have evidence of left ventricular systolic
dysfunction or symptoms of heart failure within the first 2
days after acute myocardial infarction(3,4). Tablet dosage
form contains 1, 2 or 4 mg TRA.
* Author for correspondence. Tel: +886-2-22765566 ext. 2815;
Fax: +886-2-29988028; E-mail:nurullahsanli@gmail.com

Verapamil hydrochloride (VER, (5-[3, 4-dimethoxyphenethyl) methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile hydrochloride), a slow calcium channel
antagonist, inhibits the trans membrane influx of calcium ions
into the heart and vascular smooth muscle cells (Figure 1B).
It also enhances myocardial blood flow due to the calcium
antagonistic effect on the smooth vascular muscles of coronaries. Therefore, it contributes to the anti-ischemic and
anti-anginal efficiency in all types of coronary artery diseases
and is also used as anti-hypertensive and anti-arrhythmic(5).
The film-coated tablet dosage form contains 40 mg, 80 mg,
or 120 mg of VER for oral administration.
The dissociation constant (pKa) of a drug molecule is a
key parameter in absorption, distribution, metabolism, excretion and toxicity researches because it governs solubility,
absorption, distribution and elimination of substances(6).
Also, the pKa values constitute important data for thorough
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Figure 1. Structures and dissociation equilibria of studied compounds (A) TRA, (B) VER.

understanding of certain chemical phenomena such as
biological uptake, and the binding of these molecules to
environmental matrices and forming chelates with metallic
cations. The pKa values of drugs are applied to estimate the
major species of pharmaceuticals present in the environment
(usually in neutral pH range) and dosage-form development. A satisfactory knowledge of the acid-base behavior
of substances in hydro-organic media such as methanol
(MeOH)-water is therefore essential to predict the influence
of pH on selectivity and retention during liquid chromatography (LC) and also to optimize analytical conditions for
the separation of ionizable compounds by different techniques(7,8). Although MeOH-water mobile phases have been
used in reverse phase LC (RP-LC) separation procedures, the
pKa values of VER and TRA have not yet been established in
MeOH-water binary mixtures.
Pharmaceuticals containing the combination of VER
and TRA were recently introduced into therapy. The fixeddose combinations consist of a sustained-release (SR) tablet
formulation of VER and an instant-release granulation of
TRA. While validated assays have been reported for each
drug individually(9-13), there is only one assay method that
permits quantification of all the species present, i.e., VER and
TRA(13). Besides, the analysis of weakly basic drugs such
as VER by RP-LC remains a problem, particularly when
present in combination with other drugs such as amphoteric
compounds like TRA. In this study, we propose to develop a
simple, accurate, precise and fully validated RP-LC method
for the simultaneous determination of VER and TRA in their
combined dosage forms. The proposed method will be used to
determine the combined dosage forms of TARKA FORTE®
tablets (containing 240 mg of VER and 4 mg of TRA).
The pKa values of studied compounds are either not
known accurately or not available at all. Only a limited works
related to pKa values of studied compounds are found in the

literatures(14-16). A further aim and the the novelty of this
manuscript was to determine pKa values of VER and TRA
in several MeOH-water binary mixtures, i.e., 50, 55, 60 and
65% v/v, in order to overcome the lack of information related
with the acid-base equilibria of this kind of compounds by
means of chromatographic measurements.

MATERIALS AND METHODS
I. Chemicals and Reagents
All chemicals and solvents were of analytical - reagent
grade and used without further purification. Pharmaceutically
active compounds used in this study were kindly supplied
as follows: VER and TRA from (ABBOTT Pharm. Ind.);
ramipril (RAM), an internal standard (IS) during separation studies because of its shorter elution time and similar
structure from Nobel Pharm. Ind. TARKA FORTE® tablets
(ABBOTT Pharm. Ind.) were obtained from local pharmacy.
HPLC grade MeOH and sodium hydroxide were from Merck
(Darmstadt, Germany). Ortho-phosphoric acid (min. 85%)
was from Riedel (Riedel-de Haen, Germany). Hydrochloric
acid (Titrisol) and potassium hydrogen phthalate (dried
at 110°C before use, Fluka) were used. All stock solutions
of hydrochloric acid, potassium hydroxide and potassium
hydrogen phthalate were prepared by water. Water, with
conductivity lower than 0.05 m/Scm was obtained with a
Zeneer Power I (Human Corp.)
Stock standard solutions of VER, TRA and RAM were
prepared in MeOH at 200 µg/mL. Working solutions were
diluted with the corresponding mobile phase to 10 µg/mL.
All stock and working solutions were protected from light
and stored in fridge at about 4°C. The dead time (to) was
measured by injecting uracil solution [0.01% (v/w), in water]
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which was established for each mobile phase composition
and pH studied.
II. Apparatus
The LC analysis was carried out on a Shimadzu HPLC
system with a pump (LC-20 AD), a DAD detector system
(SPD-M 20A) and column oven (CTO 20 AC). This equipment has a degasser system (DGU 20 A). The system
operates at 202, 206 and 210 nm for VER, TRA and RAM,
respectively. An X-Terra RP-18 (250 × 4.60 mm i.d. × 5 µm)
column was used as stationary phase at 40°C. Mettler Toledo
MA 235 pH/ion analyzer with Hanna HI 1332 Ag/AgCl
combined glass electrode was used for pH measurements.
III. Chromatographic Procedure
Throughout this study, the mobile phases assayed were
MeOH-water mixtures at 50, 55, 60 and 65% v/v, containing
15 mM phosphoric acid. The pH of the mobile phase was
adjusted between 2.2 and 10.0 by sodium hydroxide. The
flow rate was maintained at 1.2 mL/min and injected volume
was 20 μL.
The column was pre-conditioned for at least 1h at low
flow-rate (0.5 mL/min) with mobile phase at the corresponding pH before the first injection. For each compound,
the retention time values, tR, were determined from three
separate injections for each mobile phase composition and
pH considered.
The chromatographic retention of ionizable compounds
is strongly dependent on the pH of the mobile phase. Thus
it is required to measure and control the mobile phase pH
accurately, in many instances, for efficient separations of
ionizable compounds by LC(17).
Several procedures can be used to measure the mobile
phase pH. The most common procedure is to measurement of
the pH in the aqueous buffer before mixing it with the organic
modifier. A more rigorous procedure, recommended by the
IUPAC, is to measure the pH of the mobile phase after mixing
the aqueous buffer and the organic modifier. In this instance,
the electrode system used to measure pH can be calibrated
either with aqueous buffers, or with buffers prepared in the
same solvent composition used as mobile phase. This requires
knowledge of the pH value of reference buffers prepared in
different aqueous-organic solvent mixtures(18,19).
As pH values have been previously determined in
MeOH-water mixtures for the primary standard series of
substances proposed by National Institute of Standards and
Technology (NIST), in accordance with the IUPAC rules,
values in MeOH-water mixtures can thus be measured. In this
study, pH of the mobile phase was measured after mixing
the aqueous buffer and the organic modifier. Potassium
hydrogen phthalate solutions (0.05 mol/kg) dissolved in the
appropriate MeOH-water medium were used as primary standard buffer(20-22). In general, each methanol contents for the
chromatographic retention were studied from acid to basic
pH. pH measurements were performed in triplicate to ensure

stability and reproducibility of the mobile phase system. The
pKa values of studied compounds were determined from
k/pH data pairs by means of the non-linear regression program
NLREG(23).
IV. Preparation of Standard Solutions and Calibration
Stock solutions (100 μg/mL) of VER, TRA and RAM
(IS) were prepared in MeOH. All solutions were protected
from light and used within 24h to avoid decomposition. Standard solutions were prepared separately with mobile phase
by varying concentrations of VER and TRA in the range
of 0.5-18 μg/mL and 0.05-1.0 μg/mL, respectively and the
concentration of IS was maintained at a constant level of
2.0 μg/mL. Triplicate 20 mL injections were made for
each solution. The calibration curves for LC analysis were
constructed by plotting the peak area ratio of the drug to
that of internal standard against the drug concentration. The
proposed method was validated as to precision (reported as
the relative standard deviation, R.S.D. (%)), linearity (evaluated by regression equations), detection and determination
limits and accuracy.
The limit of detection (LOD) and limit of quantitation (LOQ) of the procedure are also obtained, which were
calculated according to the 3 s/m and 10 s/m criterions(24,25),
respectively, where s, is the standard deviation of the absorbance (n = 4) of the lowest amount of the linearity range and
m is the slope of the corresponding calibration curve.
The ruggedness and precision were checked in the same
and different days. The R.S.D. (%) values were calculated to
check the ruggedness and precision of the methods. Accuracy
was determined by recovery studies.
V. Procedure for Tablets
Ten tablets labeled to contain 240.0 mg VER and 4.0
mg TRA and excipients were weighed and finely powdered.
The powder equivalent to one tablet content was accurately
weighed, transferred into a 100 mL calibrated flask, diluted
with MeOH, stirred for about 10 min and then completed to
volume with the same solution. This solution was filtered
and the filtrate was collected in a clean flask. After filtration, appropriate solutions were prepared by taking suitable
aliquots of clear filtrate. In order to obtain a final solution, the
constant amount of IS was added and these solutions were
diluted with mobile phase and MeOH. The amounts of VER
and TRA were calculated from the corresponding regression
equations.
VI. Recovery Studies from Tablets and Laboratory Made
Mixtures
In order to demonstrate the applicability of the method,
the recovery tests were carried out by analyzing synthetic
mixtures of VER and TRA. After five repeated experiments,
the recoveries from these synthetic mixtures were calculated
for each compound.
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To verify the accuracy of the method, recovery experiments were performed by adding a known amount of pure
drug to pre-analyzed tablets. Known amounts of the pure
drug (and at a constant level of IS) were added to VER and
TRA tablet formulation and the mixtures were analyzed. The
percent recovery was calculated by comparing the concentration obtained from spiked samples with the actual added
concentration. Thus, the effect of common excipients in tablet
formulation on chromatograms (e.g., tailing, broadening) was
investigated. Recovery experiments from tablets also showed
the reliability and suitability of the method.

RESULTS AND DISCUSSION
I. Determination of Dissociation Constants (pKa)
The acid base chemistry of pharmaceutically active
compounds plays a pivotal role in the development of a new
drug. Among all the physicochemical parameters of a chemical entity, the acid dissociation constant (pKa) is one of the
most important ones. It is especially useful in the pharmaceutical industry for drug design, formulation and metabolism.
Besides, the solubility and permeability of drug compounds
are pKa dependant. pKa value also affects the drug-receptor
binding. Pharmaceuticals and the determination of useful
dosage forms and regimes for drugs depend upon an understanding of drug dissociation and the extent of dissociation
that will occur in the body systems.
Most of the ACE inhibitors contain both proton acceptor
and proton donor groups, which may be ionized and/or protonated. Their retention on column depends on the percentage of
ionized and non-ionized species of each compound. The most
dramatic pH-related changes in retention occur at pH values
within pKa ± 1.5. The ionization value helps in selecting the
pH of the buffer in the mobile phase. Thus, knowledge of
the acid-base dissociation constants of studied compounds in
MeOH-water mixtures, which are usually used as the mobile
phase, can help to improve the analytical method and can lead
to a better understanding of the chromatographic behavior of
these compounds.
Dissociation equilibria of VER and TRA are shown in
Figure 1. As deduced from Figure 1A, VER is a weak monoprotic base and the ionization process can be written as:
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where k0, k-1 and k1 are the retention factors of the neutral,
the anionic, and the cationic forms of the ampholyte and Ka1
and Ka2 are the corresponding acid dissociation constants,
respectively. The pKa values of RAM (IS) was studied as details
and reported in our previous paper(26).
In this study, the retention factors were determined for
each mobile phase composition and pH studied. In Figure 2,
data pairs of k/pH for studied compounds in 55% (v/v) MeOH
are shown and the correlation between the experimental
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Figure 2. Plot of chromatographic retention factor, k, vs. the pH of
mobile phase with 55% (v/v) of MeOH. (A) VER, (B) TRA.
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capacity factors of the compounds studied over the whole
experimental pH range was good.
Typical sigmoid shape curve was obtained for VER in
Figure 2A, showing the dependence of the analyte retention
factors upon the pH of the mobile phase, so did an ampholytic
compound shown in Figure 2B. In general, the retention of
the investigated analytes increased as the pH increased.
The dissociation constant values determined for the
equilibria involved for VER and TRA in 50, 55, 60 and
65% v/v MeOH-water mixtures at 40.0 ± 0.1°C are shown
in Table 1, together with respective standard deviations. The
Table 1 also gives the pKa values reported in the literatures,
together with those predicted using the program ACD/pKa
DB(16). ACD/pKa DB is a software program that calculates
accurate acid-base ionization constants under 25°C and zero
ionic strength in aqueous solutions for almost any organic
structure. This program uses fragment methods to build a
large number of equations with experimental or calculated
electronic constants to predict aqueous pKa values.
As deduced in Table 1, the pKa1 values of TRA associated with the carboxylic group in the proline moiety were
smaller than those generally observed with aromatic derivatives in water. pKa values of this carboxylic acid (proline)
moiety vary in the range of 2.8 to 3.1. On the other hand, the
pKa2 values correspond to the secondary amine group vary
from 3.8 to 4.1 in the studied range of MeOH.
It is well known that one of the most important factors in
determining the dissociation constants is the reaction medium.
The pKa values of VER in MeOH-water binary mixtures
decrease whereas pKa1 values of TRA in MeOH-water binary
mixtures increase and pKa2 values decrease with percentage
of MeOH. These variations could be explained by the fact that
there is preferential solvation in these media that is related to
the structural features of these binary mixtures. It has been
found that in several water-organic co-solvent mixtures, such
as MeOH-water mixtures, pKa values of a given substance
show a linear relationship with the mole fraction of organic
co-solvent(27). This is indicated by the following expression:
pKa,φ = pKa,w + φΔpK

(5)

where pKa,w indicates the dissociation constant in water, φ is
the mole fraction of organic cosolvent, ΔpK is the slope of the
linear relationship, and pKa,φ is the pKa at the corresponding
composition. The intercept, slope and correlation coefficients
9.439, -4.728, 0.991 for VER and 2.129, 2.295, 0.987 for

TRA, respectively. These results represent, in general, the
assumption of a linear relationship between pKa values of
studied compounds and the mole fraction of MeOH is a good
approximation in studied range of MeOH.
II. Analysis of Tablets
Drug analysis is undertaken during various phases
of pharmaceutical development, such as formulation and
stability studies, quality control and pharmacological testing
in animals and humans. All these investigations require reliable and validated analytical methods in order to assay drugs
in pharmaceutical formulations. Precision and accuracy can
often be enhanced by the use of an appropriate internal standard during HPLC method, which also serves to correct for
fluctuations in the detector response.
An IS is usually included in the assay when samples
require significant pretreatment or preparation. Often, a
sample preparation step that includes reaction, filtration,
precipitation, extraction, and so on, results in sample losses.
When added prior to sample preparation, a properly chosen
IS can correct these sample losses. Several compounds were
tested as possible ISs: the most suitable was ramipril (RAM).
Ideally, an internal standard should display similar physicochemical properties to the analytes. RAM was chosen as the
IS because the structure of RAM is quite similar (differ in
only one ring) to TRA and it showed shorter retention time
with better peak shape and resolution.
Various mobile phase systems were used to provide an
appropriate LC separation (50, 53, 55 and 60% v/v). Four
different types of columns such as Synergy Max-RP (5 μm,
150 mm × 4.6 mm i.d.), Symmetry Shield C-8 (5 μm, 150
mm × 3.9 mm i.d.), YMC Pack ODS-AM (5 μm, 150 mm
× 4.6 mm) and X Terra C-18 (5 μm, 250 mm × 4.6 mm i.d.)
were tested in order to find the best resolution and peak shape
of the studied compounds. X Terra C-18 column has been
selected and used successfully as a stationary phase for the
simultaneous determination and separation of VER, TRA
and IS. This stationary phase has extended pH stability and is
thermally more stable and more efficient than classical silicabased packing.
In order to find the optimum chromatographic conditions for RP-LC determination of VER, TRA and IS the
influence of pH on the mobile phase and column temperature were examined. The pH of the mobile phase has

Table 1. The pKa values of studied compounds predicted by ACD Lab(16) and obtained by chromatographic method in methanol-water media at
40°C
NLREG(20)

Compounds

Literature
values

ACD Lab

50%
(v/v)MeOH

55%
(v/v)MeOH

60%
(v/v)MeOH

65%
(v/v)MeOH

VER

8.92(14)

8.97 ± 0.50(16)

8.00 ± 0.06

7.83 ± 0.10

7.59 ± 0.07

7.39 ± 0.04

3.17 ± 0.20

2.82 ± 0.06

2.92 ± 0.05

3.03 ± 0.05

3.12 ± 0.01

5.43 ± 0.39

4.11 ± 0.11

4.04 ± 0.10

3.93 ± 0.09

3.84 ± 0.07

TRA

5.60(15)
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always been adjusted to be 2.7 with 15 mM orthophosphoric
acid, which is optimum pH with best peak asymmetry and
retention values. The column temperature was set between
25 and 40°C. Higher temperature has been shown to
minimize the tailing of the basic compounds by accelerating
the rate of interaction with the stationary phase(28). Mobile
phases containing the organic modifier methanol have been
shown to improve peak performance for basic compounds
compared to those based on acetonitrile(29). 40°C was
selected due to shorter analysis time and improved peak
shapes. Finally, the mobile phase MeOH: water 55 : 45 (v/v)
with 15 mM H3PO4 (pH 2.7) at a flow rate of 1.2 mL/min
was chosen as the most suitable carrier for LC analysis.
The proposed LC method provides a simple procedure for
the simultaneous analysis of VER and TRA in drug formulations by DAD detection at 202 and 206 nm, respectively.
Using the conditions described above, a satisfactory
chromatographic peak resolution was obtained in a short
analysis time (< 7 min.) as seen in Figure 3. For all
compounds, sharp and symmetrical single peaks were
obtained with good resolution.
System suitability for the proposed method was evaluated. The parameters tested for system suitability included
retention time, tailing factor, capacity factor, resolution,
(A)
Detector Response

a

theoretical plates, selectivity factor and RSD% of retention
time. The results from system suitability tests are presented
in Table 2 for each compound. Typically, at least two of
these criteria are required to demonstrate system suitability
for the proposed method. As shown in Table 2, the presented
chromatographic conditions ensured adequate retention of
all compounds, since capacity factor values satisfied the
conditions ( 1.0) except for those of VER and RAM. The
proposed method has also enabled good resolution of analytes
with values of resolution factors of adjacent peaks greater
than 2.0. The results obtained from system suitability tests
are in agreement with the USP requirements.
The relationship between drug concentration and the
response was linear and the proposed LC method allowed
quantitation over the 0.50-18.00 µg/mL and 0.05-1.00 µg/mL
range for VER and TRA, respectively. The calibration curves
were obtained by the linear least squares regression. Since
the correlation coefficient was not acceptable concerning
the linearity performance of the analytical procedures alone,
the SE of slope and SE of intercept were used to evaluate
the precision of the regression. These parameters should
be comparable to the RSD values which were obtained in
precision studies in the given concentration range. Linearity,
range, regression equations, correlation coefficient, LOD and
LOQ values and other related validation data are reported
in Table 3. The low values of SE of intercept and slope and
correlation coefficient > 0.999 in mobile phase, established
Table 2. System suitability parameters

IS

VER

RAM
(IS)

TRA

Retention time (min)

2.964

3.910

5.497

Tailing factor (T)

1.278

1.134

1.116

Capacity factor

0.322

0.744

1.452

≥1

b
1 2
0.5

1.0

1.5

2.0

2.5

3.0

3.5

4.0

4.5

5.0

5.5

6.0

Time/min
(B)
IS

a

Detector Response

≤2

Resolution (R)

3.557

-

5.122

>2

Theoretical plates (N)

3400

3457

5035

> 2000

Selectivity factor (α)

2.311

-

1.952

> 1.15

0.183

0.180

≤1

RSD% (for retention time) 0.187

a

Recommended
value

b

Table 3. Statistical evaluation of the calibration data of verapamil and
trandolapril by RP-HPLC
IS

0.0

1.0

2.0

3.0

4.0

b
5.0

VER

TRA

0.50-18.00
(n = 8)

0.05-1.00
(n = 7)

Slope

2.179

0.494

Intercept

-0.311

0.002

SE of slope

0.008

0.002

SE of intercept

0.083

0.004

Correlation coefficient (r)

0.9999

0.9999

Detection limit (LOD) (μg/mL)

0.008

0.018

Quantitation limit (LOQ) (μg/mL)

0.025

0.050

Linearity range
(μg/mL)
6.0

7.0

Time/min
Figure 3. (A) Chromatogram of a standard mixture of studied
compounds (1) Mobile phase and (2) mobile phase containing 10 µg/
mL VER (a), 25 µg/mL TRA (b) and 15 µg/mL RAM (IS). The eluents
were monitored at 202 nm. (B) Chromatogram of tablet dosage forms
(Tarka Forte®), (1) Mobile phase and (2) mobile phase containing 12.0
µg/mL VER (a), 0.2 µg/mL TRA (b) and 2.0 µg/mL RAM (IS). Mobile
phase consist of MeOH: water (55 : 45, v/v) mixture containing 15 mM
H3PO4, with the pH adjusted to 2.70 with NaOH.

SE is standard error.
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the precision of the proposed method.
Precision and reproducibility of the method were
evaluated by doing replicate analysis of standard solutions
in the mobile phase. Repeatability and reproducibility were
characterized by mean recovery and RSD and the results are
summarized in Table 4. As deduced from Table 4, there was
no significant difference for the assay, as tested by withinday and between days. The RSD% values were between
0.088 and 3.443 for VER and 0.029 and 2.672 for TRA for
the studied concentrations. These results supported good
precision of the method.
In order to show the accuracy, validity and applicability
of the proposed method, recovery tests have been performed
by analyzing laboratory-made mixtures of VER and TRA
which reproduced four different ratios (Table 5).
The mean percentage recoveries obtained after five
repeated experiments were between 99.99 and 100.30 for
VER and 99.38 and 101.60 for TRA with low level of RSD
values at about 0.671 and 1.399 for VER and TRA, respectively. It is concluded, that the proposed method is sufficiently

Table 4. Summary of repeatability (intra-day) and reproducibility
(inter-day) precision data for verapamil and trandolapril
Intra-day

Inter-day

Mean Recovery* %
± RSD%

Mean Recovery* %
± RSD%

1

99.761 ± 0.545

100.680 ± 3.443

10

100.164 ± 0.088

99.642 ± 0.205

15

100.021 ± 0.098

99.978 ± 0.245

0.1

99.932 ± 0.117

99.879 ± 2.672

0.4

99.966 ± 0.029

99.555 ± 1.197

0.8

99.907 ± 0.130

100.116 ± 0.666

Compound
concentration
(μg/mL)
Verapamil

Trandolapril

*Each value is obtained from five experiments (n = 5).

accurate and precise in order to be applied to pharmaceutical
dosage forms. High percentage recovery data shows that the
method is free from the interferences of the excipients used
in the formulations.
The results from the laboratory-made mixtures (Figure
3A), analysis by the proposed LC method were extended
to the simultaneous determination of VER and TRA in
commercial tablet forms. This method can be used successfully in the presence of each drug without prior separation
of the excipients. Each tablet contains the active ingredients of 240 mg of VER as verapamil hydrochloride, 4 mg
TRA and the inactive ingredients as the excipients. It was
found that the removal of the excipients before analysis was
unnecessary (Figure 3B).
Figure 3 shows a chromatogram of the separation of
mixtures of VER, TRA and IS in a mobile phase of MeOHwater with 55% (v/v) at pH 2.7. The studied compounds
appeared as symmetrical single peaks, forming well shaped,
perfectly separated from the solvent front and each other.
The peak of TRA is enlarged in the chromatogram because
of the quantity of the studied compound in the mixture and in
the pharmaceutical dosage form. Additionally, no interfering
peak was obtained in the analysis due to tablet excipients.
The use of proposed LC method was verified by means of
replicate estimations of pharmaceutical preparations and
results were analyzed statistically and given in Table 6. It can
be concluded that the proposed method can be employed for
simultaneous quantitation and routine quality control analysis
of this binary mixture in pharmaceuticals. A short analysis
time for high-throughput analysis is most desirable and a
preliminary review of literatures showed that the currently
reported methods were unsuitable for the analysis of the drug
combination. High percentage recovery data shows that the
proposed LC method is free from the interferences of the
excipients used in the formulations.
The stability of the reference compounds and sample

Table 5. Determination of verapamil and trandolapril in laboratory-made mixtures
Compounds (μg/mL)
VER

TRA

Found*
VER

Recovery%
TRA

VER

TRA

Bias%

RSD%

VER

TRA

VER

TRA

1

0.2

1.013

0.197

101.30

98.50

-1.3

1.5

2.187

1.943

5

0.2

4.989

0.200

99.78

100.00

0.22

0

0.132

0.559

12

0.2

12.004

0.199

100.03

99.50

-0.03

0.5

0.288

1.700

18

0.2

18.013

0.199

100.07

99.50

-0.07

0.5

0.077

1.188

Mean Recovery

100.30

99.38

RSD%

0.671

1.348

12

0.05

11.999

0.050

99.99

100.00

0.01

0

0.340

2.692

12

0.10

12.019

0.103

100.16

103.00

-0.16

-3.0

0.057

0.915

12

0.20

11.985

0.200

99.88

100.00

0.12

0

0.159

1.121

12

1.00

11.991

1.034

99.93

103.40

0.07

-3.4

0.198

0.869

Mean Recovery

99.99

101.60

RSD%

0.189

1.399

*The mean of five experiments.
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Table 6. Results of the assay and the recovery analysis of verapamil
and trandolapril in pharmaceutical dosage forms
Verapamil
Labeled claim (mg)

240.00

4.00

Amount found (mg)a

239.87

3.96

0.14

1.56

RSD (%)
Bias (%)

0.05

1.05

Added (mg)

240.00

4.00

a

240.04

4.01

100.02

100.12

0.085

0.35

-0.016

-0.116

Found (mg)

Recovery (%)
RSD% of recovery
Bias (%)
a

Trandolapril

Each value of the mean five experiments.

solutions were examined by analyzing standard solutions of
the compounds in the mobile phase aged at +4°C, in the dark
against a freshly prepared sample. The results demonstrated
that the working reference solutions were stable for up to one
week. The obtained peak area ratio for the assay reference
solutions did not change considerably over a week period.

CONCLUSIONS
This work presents the first study dealing with the
determination of pKa values of VER and TRA by chromatographic method in MeOH-water binary mixtures. The
pKa values of studied compounds are useful for facilitating
occurrence, effects, and control of ACE inhibitors in scientific studies for investigators. Dependence of retention of
ACE inhibitors on pH of the mobile phase was determined
using LC methodology and the results were applied for the
determination of pKa values.
Using the chromatographic system presented here, the
separation of weakly basic and amphoteric compounds has
been performed. This was attributed to the careful selection
of the column, which decreased the negative interactions
between the stationary phase and the charged basic species
that can lead to peak broadening. The proposed method gives
a good resolution between VER, TRA and internal standard
within a short analysis time. The chromatographic system
can be used to concurrent analysis of VER and TRA within
a short analysis time (< 7 min), without either interfering in
the detection or quantitation of the other inactive ingredients or possible interferences. The developed HPLC method
was validated by evaluation of the required validation
parameters. The LOD and LOQ values, precision, accuracy,
resolution, selectivity, tailing, and capacity factors, etc were
obtained. The present study proposes a rapid, simple, sufficiently precise, and accurate method for the simultaneous
determination of VER, TRA in raw material and pharmaceutical dosage forms. High percentages of recovery show that
the method is free from the interferences of the commonly

used excipients and additives in the formulations of the drug.
The proposed method is more sensitive, rapid and precise
than the literature method. The assay method can be used
as a versatile analytical tool suitable for the simultaneous
analysis of these drugs and would be of interest for quality
control and clinical monitoring laboratories to evaluate
product performance of a combined tablet dosage forms.
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